Drug Use During Sex and Its Impact on Taking PrEP (Pre-Exposure Prophylaxis) : CONSUME

Completed

• Conditions: Drug Dependence
• Interventions: Behavioral: self-questionnaire

• Registration Number: NCT04709016
• Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Brief Summary

This is a cross-sectional, single-center observational study conducted from October 2020 to March 2021 in Ile de France at the infectious disease of CHU Bichat (PrEP and CeGIDD(Free Center for Information, Screening and Diagnosis of Infections by Human Immunodeficiency Viruses, Viral Hepatitis and Sexually Transmitted Infections) consultation). It concerns adult subjects of male or transgender sex, of MSM (men having sex with men) or bi-sexual orientation. The data are collected by self-questionnaire evaluating the consumption of Chemsex (drug use in a sexual context) over the last 12 months, the existence or not of addiction treatment, the history of STIs (sexually transmitted infections) and adherence to PrEP (for subjects taking PrEP) during the last sexual intercourse (ANRS questionnaire, used in the PREVENIR study).

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-01-07
• Study First Submitted QC: 2021-01-12
• Study First Posted: 2021-01-14
• Study Start: 2021-03-18
• Status Verified: 2021-05
• Primary Completion: 2022-03-25
• Study Completion: 2022-03-25
• Last Update Submitted: 2022-08-29
• Last Update Posted: 2022-08-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 100

Inclusion Criteria

• age> 18
• male or transgender
• MSM or bi-sexual orientation
• adult consultant at Bichat Hospital (CeGIDD or PrEP consultation)
• adult with a Smartphone (online self-questionnaire)

Exclusion Criteria

• For the group "taking PrEP": adult taking PrEP for less than 3 months
• Refusal of participation

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
male or transgender patients	self-questionnaire	of sexual orientation MSM (men having sex with men) or bi-sexual, consultant in sexual health centers

Primary Outcome Measures

Name	Time	Method
compare in an MSM and transgender population, the use of Chemsex depending on whether or not PrEP is taken	inclusion

Secondary Outcome Measures

Name	Time	Method
The number of sexually transmitted infections at inclusion	inclusion
The existence or not of psychological comorbidity and the existence of addictological care	inclusion
Reported adherence to PrEP	inclusion

Trial Locations

Locations (1)

SMIT - Hôpital Bichat; 🇫🇷 Paris, France